These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29627126)

  • 1. Vaccination against tuberculosis.
    Martin C; Aguilo N; Gonzalo-Asensio J
    Enferm Infecc Microbiol Clin (Engl Ed); 2018 Dec; 36(10):648-656. PubMed ID: 29627126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis.
    Clark S; Lanni F; Marinova D; Rayner E; Martin C; Williams A
    J Infect Dis; 2017 Sep; 216(5):525-533. PubMed ID: 28329234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic.
    Gonzalo-Asensio J; Marinova D; Martin C; Aguilo N
    Front Immunol; 2017; 8():1803. PubMed ID: 29326700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial.
    Spertini F; Audran R; Chakour R; Karoui O; Steiner-Monard V; Thierry AC; Mayor CE; Rettby N; Jaton K; Vallotton L; Lazor-Blanchet C; Doce J; Puentes E; Marinova D; Aguilo N; Martin C
    Lancet Respir Med; 2015 Dec; 3(12):953-62. PubMed ID: 26598141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?
    Moliva JI; Turner J; Torrelles JB
    Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New tuberculosis vaccines.
    Martín Montañés C; Gicquel B
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?
    Martín C
    Eur Respir J; 2005 Jul; 26(1):162-7. PubMed ID: 15994403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MTBVAC from discovery to clinical trials in tuberculosis-endemic countries.
    Marinova D; Gonzalo-Asensio J; Aguilo N; Martin C
    Expert Rev Vaccines; 2017 Jun; 16(6):565-576. PubMed ID: 28447476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
    PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of vaccination trials for control of tuberculosis in cattle, wildlife and humans.
    Buddle BM; Parlane NA; Wedlock DN; Heiser A
    Transbound Emerg Dis; 2013 Nov; 60 Suppl 1():136-46. PubMed ID: 24171859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice.
    Aguilo N; Uranga S; Marinova D; Monzon M; Badiola J; Martin C
    Tuberculosis (Edinb); 2016 Jan; 96():71-4. PubMed ID: 26786657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with heat-killed Mycobacterium bovis bacille Calmette-Guerin (BCG) in Eurocine L3 adjuvant protects against tuberculosis.
    Haile M; Schröder U; Hamasur B; Pawlowski A; Jaxmar T; Källenius G; Svenson SB
    Vaccine; 2004 Mar; 22(11-12):1498-508. PubMed ID: 15063575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyper-attenuated MTBVAC erp mutant protects against tuberculosis in mice.
    Solans L; Uranga S; Aguilo N; Arnal C; Gomez AB; Monzon M; Badiola JJ; Gicquel B; Martin C
    Vaccine; 2014 Sep; 32(40):5192-7. PubMed ID: 25066740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the bacille Calmette-Guérin vaccination for the prevention of tuberculosis: renewed interest in an old vaccine.
    Cohn DL
    Am J Med Sci; 1997 Jun; 313(6):372-6. PubMed ID: 9186153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis.
    Xing Z; Charters TJ
    Expert Rev Vaccines; 2007 Aug; 6(4):539-46. PubMed ID: 17669008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review protocol on Bacillus Calmette-Guerin (BCG) revaccination and protection against tuberculosis.
    Mahasha PW; Ndwandwe DE; Mavundza EJ; Shey M; Wiysonge CS
    BMJ Open; 2019 Oct; 9(10):e027033. PubMed ID: 31619416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis.
    Buddle BM; Wards BJ; Aldwell FE; Collins DM; de Lisle GW
    Vaccine; 2002 Jan; 20(7-8):1126-33. PubMed ID: 11803073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated Bacille Calmette-Guerin (BCG) disease in an infant with severe combined immunodeficiency.
    Sohail S; Afzal M; Anwar V; Shama Q
    J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S259-61. PubMed ID: 25518795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.